Cross-sectional survey reveals high confidence in a new malaria vaccine in households, indicating potential support for public health goals.
Ghana aims to reduce malaria incidence by 50% and malaria mortality by 90% by 2028. The new R21 malaria vaccine aims to support achieving malaria-elimination goals, but it must be met with high population confidence and uptake. In this cross-sectional household survey in Karaga District, northern Ghana, 99.4% (n=175) agreed malaria is a serious disease to children, while 90.9% (n=160) agreed or strongly agreed they would like their children aged <5 y to take the new vaccine. Thus, in these communities, the highly effective vaccine can plausibly expect to have high rates of uptake, contributing to Ghana's efforts to improve health outcomes.
No takes yet. Share an insight, caveat, or question.
Gregory et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: